Friday, 24 April, 2009

Memantine: SPC revocation decision delayed

SPC revocation decision on alzheimer treatment medication Memantine has delayed in UK. The Judge in the UK came to the conclusion that he needed to refer questions on the legal interpretation of the SPC Regulation to the European Court of Justice for clarification of the position. The said decision can further take some time, however, commercially, generic player Synthon (who has opposed the SPC) will have to wait for final decision from court.

Link to court decision Here

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
eXTReMe Tracker